Van ECK Associates Corp decreased its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 69.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,758 shares of the insurance provider’s stock after selling 8,739 shares during the quarter. Van ECK Associates Corp’s holdings in Humana were worth $1,493,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Wilkerson Advisory Group LLC increased its position in Humana by 24.6% during the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after purchasing an additional 33 shares in the last quarter. Bogart Wealth LLC boosted its position in Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares in the last quarter. Fiduciary Alliance LLC grew its stake in shares of Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after buying an additional 49 shares during the last quarter. Horizon Investments LLC increased its holdings in shares of Humana by 2.5% during the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after buying an additional 55 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in shares of Humana during the second quarter worth $26,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Humana Stock Down 1.4%
Shares of NYSE HUM opened at $400.70 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The company has a 50-day moving average price of $388.44 and a 200-day moving average price of $296.00. The stock has a market capitalization of $48.12 billion, a P/E ratio of 37.91, a P/E/G ratio of 2.67 and a beta of 0.74. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88.
Humana Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s payout ratio is presently 33.49%.
Analyst Ratings Changes
A number of brokerages recently weighed in on HUM. Royal Bank Of Canada boosted their price objective on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. TD Cowen boosted their price target on Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. Morgan Stanley upgraded shares of Humana from an “underweight” rating to an “equal weight” rating and raised their price objective for the company from $249.00 to $370.00 in a report on Tuesday, August 4th. Zacks Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, Barclays upped their price target on Humana from $344.00 to $407.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Humana has an average rating of “Hold” and an average price target of $403.91.
Get Our Latest Stock Analysis on HUM
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
